{"id":40431,"date":"2025-01-13T21:58:40","date_gmt":"2025-01-13T21:58:40","guid":{"rendered":"https:\/\/www.africa-press.net\/eritrea\/all-news\/gsk-to-buy-us-biopharmaceutical-company-idrx-for-1-15b"},"modified":"2025-01-13T21:58:40","modified_gmt":"2025-01-13T21:58:40","slug":"gsk-to-buy-us-biopharmaceutical-company-idrx-for-1-15b","status":"publish","type":"post","link":"https:\/\/www.africa-press.net\/eritrea\/all-news\/gsk-to-buy-us-biopharmaceutical-company-idrx-for-1-15b","title":{"rendered":"GSK to buy US biopharmaceutical company IDRx for $1.15B"},"content":{"rendered":"<p><span style=\"color: #ff6600\"><strong>Africa-Press &#8211; Eritrea. <\/strong><\/span>British drug maker GSK on Monday said it will buy US biopharmaceutical company IDRx for up to $1.15 billion.<\/p>\n<p>The Boston-based biotechnology firm is developing therapeutics for the treatment of gastrointestinal stromal tumors.<\/p>\n<p>GSK will make a $1 billion upfront payment, with the possibility of a $150 million follow-on milestone payments.<\/p>\n<p>&#8220;This acquisition is consistent with our approach of acquiring assets that address validated targets and where there is clear unmet medical need, despite existing approved products,&#8221; GSK&#8217;s Chief Commercial Officer Luke Miels said in a statement.<\/p>\n<p>\u201cWe are looking forward to working with GSK to advance IDRX-42 for patients with GIST given there have been no major advances to the standard of care for almost 20 years,&#8221; said Tim Clackson, CEO of the privately-held IDRx.<\/p>\n<p>&#8220;Combining our experience to date with GSK\u2019s expertise in GI cancers, global clinical development capability, and strong commercial presence in oncology will help to accelerate the development of this novel medicine for patients,&#8221; he added.\u200b\u200b\u200b\u200b\u200b\u200b\u200b<\/p>\n<p><strong>For More News And Analysis About <span style=\"color: #ff6600\">Eritrea<\/span> Follow <span style=\"color: #ff6600\">Africa-Press<\/span><\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Africa-Press &#8211; Eritrea. British drug maker GSK on Monday said it will buy US biopharmaceutical company IDRx for up to $1.15 billion. The Boston-based biotechnology firm is developing therapeutics for the treatment of gastrointestinal stromal tumors. GSK will make a $1 billion upfront payment, with the possibility of a $150 million follow-on milestone payments. &#8220;This [&hellip;]<\/p>\n","protected":false},"author":84,"featured_media":40430,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2,9],"tags":[1012,233,6311,6310],"class_list":["post-40431","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-all-news","category-miscellaneous","tag-cancer","tag-eritrea","tag-gsk","tag-idrx"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v26.1 (Yoast SEO v27.0) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>GSK to buy US biopharmaceutical company IDRx for $1.15B - Eritrea<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.africa-press.net\/eritrea\/all-news\/gsk-to-buy-us-biopharmaceutical-company-idrx-for-1-15b\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"GSK to buy US biopharmaceutical company IDRx for $1.15B\" \/>\n<meta property=\"og:description\" content=\"Africa-Press &#8211; Eritrea. British drug maker GSK on Monday said it will buy US biopharmaceutical company IDRx for up to $1.15 billion. The Boston-based biotechnology firm is developing therapeutics for the treatment of gastrointestinal stromal tumors. GSK will make a $1 billion upfront payment, with the possibility of a $150 million follow-on milestone payments. &#8220;This [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.africa-press.net\/eritrea\/all-news\/gsk-to-buy-us-biopharmaceutical-company-idrx-for-1-15b\" \/>\n<meta property=\"og:site_name\" content=\"Eritrea\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/AfricaPressTunisiaa\" \/>\n<meta property=\"article:published_time\" content=\"2025-01-13T21:58:40+00:00\" \/>\n<meta name=\"author\" content=\"cfeditoren\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"cfeditoren\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.africa-press.net\/eritrea\/all-news\/gsk-to-buy-us-biopharmaceutical-company-idrx-for-1-15b#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.africa-press.net\/eritrea\/all-news\/gsk-to-buy-us-biopharmaceutical-company-idrx-for-1-15b\"},\"author\":{\"name\":\"cfeditoren\",\"@id\":\"https:\/\/www.africa-press.net\/eritrea\/#\/schema\/person\/068c7ab4e9634ae78ec5d54ec46598bb\"},\"headline\":\"GSK to buy US biopharmaceutical company IDRx for $1.15B\",\"datePublished\":\"2025-01-13T21:58:40+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.africa-press.net\/eritrea\/all-news\/gsk-to-buy-us-biopharmaceutical-company-idrx-for-1-15b\"},\"wordCount\":180,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/www.africa-press.net\/eritrea\/all-news\/gsk-to-buy-us-biopharmaceutical-company-idrx-for-1-15b#primaryimage\"},\"thumbnailUrl\":\"https:\/\/static.africa-press.net\/eritrea\/sites\/27\/2025\/01\/sm_1736794921.978585.jpg\",\"keywords\":[\"Cancer\",\"Eritrea\",\"GSK\",\"IDRx\"],\"articleSection\":[\"all news\",\"miscellaneous\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.africa-press.net\/eritrea\/all-news\/gsk-to-buy-us-biopharmaceutical-company-idrx-for-1-15b#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.africa-press.net\/eritrea\/all-news\/gsk-to-buy-us-biopharmaceutical-company-idrx-for-1-15b\",\"url\":\"https:\/\/www.africa-press.net\/eritrea\/all-news\/gsk-to-buy-us-biopharmaceutical-company-idrx-for-1-15b\",\"name\":\"GSK to buy US biopharmaceutical company IDRx for $1.15B - Eritrea\",\"isPartOf\":{\"@id\":\"https:\/\/www.africa-press.net\/eritrea\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.africa-press.net\/eritrea\/all-news\/gsk-to-buy-us-biopharmaceutical-company-idrx-for-1-15b#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.africa-press.net\/eritrea\/all-news\/gsk-to-buy-us-biopharmaceutical-company-idrx-for-1-15b#primaryimage\"},\"thumbnailUrl\":\"https:\/\/static.africa-press.net\/eritrea\/sites\/27\/2025\/01\/sm_1736794921.978585.jpg\",\"datePublished\":\"2025-01-13T21:58:40+00:00\",\"author\":{\"@id\":\"https:\/\/www.africa-press.net\/eritrea\/#\/schema\/person\/068c7ab4e9634ae78ec5d54ec46598bb\"},\"breadcrumb\":{\"@id\":\"https:\/\/www.africa-press.net\/eritrea\/all-news\/gsk-to-buy-us-biopharmaceutical-company-idrx-for-1-15b#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.africa-press.net\/eritrea\/all-news\/gsk-to-buy-us-biopharmaceutical-company-idrx-for-1-15b\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.africa-press.net\/eritrea\/all-news\/gsk-to-buy-us-biopharmaceutical-company-idrx-for-1-15b#primaryimage\",\"url\":\"https:\/\/static.africa-press.net\/eritrea\/sites\/27\/2025\/01\/sm_1736794921.978585.jpg\",\"contentUrl\":\"https:\/\/static.africa-press.net\/eritrea\/sites\/27\/2025\/01\/sm_1736794921.978585.jpg\",\"width\":864,\"height\":486,\"caption\":\"GSK to buy US biopharmaceutical company IDRx for $1.15B\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.africa-press.net\/eritrea\/all-news\/gsk-to-buy-us-biopharmaceutical-company-idrx-for-1-15b#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.africa-press.net\/eritrea\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"GSK to buy US biopharmaceutical company IDRx for $1.15B\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.africa-press.net\/eritrea\/#website\",\"url\":\"https:\/\/www.africa-press.net\/eritrea\/\",\"name\":\"Eritrea\",\"description\":\"Just another Africa News Agency Sites site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.africa-press.net\/eritrea\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.africa-press.net\/eritrea\/#\/schema\/person\/068c7ab4e9634ae78ec5d54ec46598bb\",\"name\":\"cfeditoren\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.africa-press.net\/eritrea\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/7417380fa9e23b5c57fdbfdaf3fdf92ee478f759a084addda5faa3732853e74a?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/7417380fa9e23b5c57fdbfdaf3fdf92ee478f759a084addda5faa3732853e74a?s=96&d=mm&r=g\",\"caption\":\"cfeditoren\"}}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"GSK to buy US biopharmaceutical company IDRx for $1.15B - Eritrea","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.africa-press.net\/eritrea\/all-news\/gsk-to-buy-us-biopharmaceutical-company-idrx-for-1-15b","og_locale":"en_US","og_type":"article","og_title":"GSK to buy US biopharmaceutical company IDRx for $1.15B","og_description":"Africa-Press &#8211; Eritrea. British drug maker GSK on Monday said it will buy US biopharmaceutical company IDRx for up to $1.15 billion. The Boston-based biotechnology firm is developing therapeutics for the treatment of gastrointestinal stromal tumors. GSK will make a $1 billion upfront payment, with the possibility of a $150 million follow-on milestone payments. &#8220;This [&hellip;]","og_url":"https:\/\/www.africa-press.net\/eritrea\/all-news\/gsk-to-buy-us-biopharmaceutical-company-idrx-for-1-15b","og_site_name":"Eritrea","article_publisher":"https:\/\/www.facebook.com\/AfricaPressTunisiaa","article_published_time":"2025-01-13T21:58:40+00:00","author":"cfeditoren","twitter_card":"summary_large_image","twitter_misc":{"Written by":"cfeditoren","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.africa-press.net\/eritrea\/all-news\/gsk-to-buy-us-biopharmaceutical-company-idrx-for-1-15b#article","isPartOf":{"@id":"https:\/\/www.africa-press.net\/eritrea\/all-news\/gsk-to-buy-us-biopharmaceutical-company-idrx-for-1-15b"},"author":{"name":"cfeditoren","@id":"https:\/\/www.africa-press.net\/eritrea\/#\/schema\/person\/068c7ab4e9634ae78ec5d54ec46598bb"},"headline":"GSK to buy US biopharmaceutical company IDRx for $1.15B","datePublished":"2025-01-13T21:58:40+00:00","mainEntityOfPage":{"@id":"https:\/\/www.africa-press.net\/eritrea\/all-news\/gsk-to-buy-us-biopharmaceutical-company-idrx-for-1-15b"},"wordCount":180,"commentCount":0,"image":{"@id":"https:\/\/www.africa-press.net\/eritrea\/all-news\/gsk-to-buy-us-biopharmaceutical-company-idrx-for-1-15b#primaryimage"},"thumbnailUrl":"https:\/\/static.africa-press.net\/eritrea\/sites\/27\/2025\/01\/sm_1736794921.978585.jpg","keywords":["Cancer","Eritrea","GSK","IDRx"],"articleSection":["all news","miscellaneous"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.africa-press.net\/eritrea\/all-news\/gsk-to-buy-us-biopharmaceutical-company-idrx-for-1-15b#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.africa-press.net\/eritrea\/all-news\/gsk-to-buy-us-biopharmaceutical-company-idrx-for-1-15b","url":"https:\/\/www.africa-press.net\/eritrea\/all-news\/gsk-to-buy-us-biopharmaceutical-company-idrx-for-1-15b","name":"GSK to buy US biopharmaceutical company IDRx for $1.15B - Eritrea","isPartOf":{"@id":"https:\/\/www.africa-press.net\/eritrea\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.africa-press.net\/eritrea\/all-news\/gsk-to-buy-us-biopharmaceutical-company-idrx-for-1-15b#primaryimage"},"image":{"@id":"https:\/\/www.africa-press.net\/eritrea\/all-news\/gsk-to-buy-us-biopharmaceutical-company-idrx-for-1-15b#primaryimage"},"thumbnailUrl":"https:\/\/static.africa-press.net\/eritrea\/sites\/27\/2025\/01\/sm_1736794921.978585.jpg","datePublished":"2025-01-13T21:58:40+00:00","author":{"@id":"https:\/\/www.africa-press.net\/eritrea\/#\/schema\/person\/068c7ab4e9634ae78ec5d54ec46598bb"},"breadcrumb":{"@id":"https:\/\/www.africa-press.net\/eritrea\/all-news\/gsk-to-buy-us-biopharmaceutical-company-idrx-for-1-15b#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.africa-press.net\/eritrea\/all-news\/gsk-to-buy-us-biopharmaceutical-company-idrx-for-1-15b"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.africa-press.net\/eritrea\/all-news\/gsk-to-buy-us-biopharmaceutical-company-idrx-for-1-15b#primaryimage","url":"https:\/\/static.africa-press.net\/eritrea\/sites\/27\/2025\/01\/sm_1736794921.978585.jpg","contentUrl":"https:\/\/static.africa-press.net\/eritrea\/sites\/27\/2025\/01\/sm_1736794921.978585.jpg","width":864,"height":486,"caption":"GSK to buy US biopharmaceutical company IDRx for $1.15B"},{"@type":"BreadcrumbList","@id":"https:\/\/www.africa-press.net\/eritrea\/all-news\/gsk-to-buy-us-biopharmaceutical-company-idrx-for-1-15b#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.africa-press.net\/eritrea\/"},{"@type":"ListItem","position":2,"name":"GSK to buy US biopharmaceutical company IDRx for $1.15B"}]},{"@type":"WebSite","@id":"https:\/\/www.africa-press.net\/eritrea\/#website","url":"https:\/\/www.africa-press.net\/eritrea\/","name":"Eritrea","description":"Just another Africa News Agency Sites site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.africa-press.net\/eritrea\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.africa-press.net\/eritrea\/#\/schema\/person\/068c7ab4e9634ae78ec5d54ec46598bb","name":"cfeditoren","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.africa-press.net\/eritrea\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/7417380fa9e23b5c57fdbfdaf3fdf92ee478f759a084addda5faa3732853e74a?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/7417380fa9e23b5c57fdbfdaf3fdf92ee478f759a084addda5faa3732853e74a?s=96&d=mm&r=g","caption":"cfeditoren"}}]}},"_links":{"self":[{"href":"https:\/\/www.africa-press.net\/eritrea\/wp-json\/wp\/v2\/posts\/40431","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.africa-press.net\/eritrea\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.africa-press.net\/eritrea\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.africa-press.net\/eritrea\/wp-json\/wp\/v2\/users\/84"}],"replies":[{"embeddable":true,"href":"https:\/\/www.africa-press.net\/eritrea\/wp-json\/wp\/v2\/comments?post=40431"}],"version-history":[{"count":0,"href":"https:\/\/www.africa-press.net\/eritrea\/wp-json\/wp\/v2\/posts\/40431\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.africa-press.net\/eritrea\/wp-json\/wp\/v2\/media\/40430"}],"wp:attachment":[{"href":"https:\/\/www.africa-press.net\/eritrea\/wp-json\/wp\/v2\/media?parent=40431"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.africa-press.net\/eritrea\/wp-json\/wp\/v2\/categories?post=40431"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.africa-press.net\/eritrea\/wp-json\/wp\/v2\/tags?post=40431"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}